Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05355597
Other study ID # 1429450
Secondary ID
Status Recruiting
Phase Phase 2
First received
Last updated
Start date January 27, 2021
Est. completion date July 7, 2023

Study information

Verified date April 2022
Source Morristown Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this proposed project is to determine which local anesthetic is more efficacious for use in soft tissue tumors: Exparel (liposomal bupivacaine) or a cocktail of Ropivicaine, Epinepherine, Ketolorac and Clonidine. This study will examine patients' post-operative pain levels as well as their narcotic consumption after removal of a soft tissue tumor while hospitalized and then twice daily through postoperative day 14.


Description:

In recent years, there has been a substantial push to create a post-surgical protocol consisting of multimodal analgesia across multiple surgical subspecialties to decrease narcotic consumption and cost1. The negative side effects of narcotics and their addiction potential are well understood. One of the modes of analgesia currently in use to mitigate surgical pain is some form of local anesthetic. Increasing the duration of analgesia has been sought after since its inception. Subsequently, longer acting anesthetics like bupivacaine have been implemented as well as supplementing their use with other drugs, such as epinephrine, to increase their effect duration and overall efficacy2. This has led to the development of Liposomal Bupivicaine or Exparel (TM, Parsippany NJ etc.) Exparel works by infusing liposomes in the administration of the long acting local analgesic which entrap the biologically active drug and slowly release it over a period of 72-96 hours 3-4. Thus, post-operative pain can be managed via direct injection of the drug at the surgical site with upwards to four days of pain relief. Exparel has been studied extensively in the surgical literature; although within orthopedics, it has been primarily in regard to arthroplasty5. There has yet to be a study to illicit the best form of post-operative pain control in the world of orthopedic oncology, specifically in soft tissue tumors. The objective of this proposed project is to determine which local anesthetic is more efficacious for use in soft tissue tumors: Exparel (liposomal bupivacaine) or a cocktail of Ropivicaine, Epinepherine, Ketolorac and Clonidine. This study will examine patients' post-operative pain levels as well as their narcotic consumption after removal of a soft tissue tumor while hospitalized and then twice daily through postoperative day 14.


Recruitment information / eligibility

Status Recruiting
Enrollment 140
Est. completion date July 7, 2023
Est. primary completion date July 7, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All primary soft tissue tumors - Any adult patient (over 18 years old) with a soft tissue tumor confirmed with advanced imaging. Two different study groups will be examined: - Those patients undergoing resection of their soft tissue tumor intraoperatively injected with Exparel - Those patients undergoing resection of their soft tissue tumor intraoperatively injected with the cocktail. - Those two groups will be further stratified by anatomic location; Upper vs lower extremity, size; tumors = 10cm, tumors = 5cm, tumors < 5cm, and depth; superficial vs deep. Exclusion Criteria: - Pediatric Patients - Patients without soft tissue tumors - Tylenol or oxycodone allergy

Study Design


Intervention

Drug:
Exparel Injectable Product
Both drugs have same desired effect. Will be injected intra-operatively while subjects are under anesthesia to alleviate significant post-operative pain.
Multi-Drug Cocktail (Ropivicaine, Epinephrine, Ketolorac, Clonidine)
Same desired effect as Exparel but different mechanism of action. Will be injected intra-operatively while subjects are under anesthesia to alleviate significant post-operative pain.

Locations

Country Name City State
United States Morristown Medical Center Morristown New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Morristown Medical Center

Country where clinical trial is conducted

United States, 

References & Publications (4)

Barrington JW. Efficacy of Periarticular Injection With a Long-Acting Local Analgesic in Joint Arthroplasty. Am J Orthop (Belle Mead NJ). 2015 Oct;44(10 Suppl):S13-6. — View Citation

Bramlett K, Onel E, Viscusi ER, Jones K. A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplas — View Citation

Kelly MA. Current Postoperative Pain Management Protocols Contribute to the Opioid Epidemic in the United States. Am J Orthop (Belle Mead NJ). 2015 Oct;44(10 Suppl):S5-8. — View Citation

Ranade VV. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers. J Clin Pharmacol. 1989 Aug;29(8):685-94. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Outcomes Pain will be recorded on a sheet for each patient. Self-reported, patient will describe pain each day on a scale of 1-10 (10 being the worst) 14 days
Secondary Medication Consumption Patient will self-report how much medication he or she took each day post-operatively. 14 days
See also
  Status Clinical Trial Phase
Withdrawn NCT04976972 - A Comparison of Patients Receiving a Total Knee Replacement With Robotic Assistance or With Conventional Instrumentation N/A
Recruiting NCT05546541 - Epidemiology and Nutrition
Completed NCT05071469 - Comparison of Two Different Treatment Methods N/A
Completed NCT05041400 - Distribution of Knee Isokinetic Angle-specific Moments and Ratios N/A
Not yet recruiting NCT06216028 - Bone Marrow Aspirate Concentrate (BMAC) Treatment for Knee Osteoarthritis Phase 3
Not yet recruiting NCT04932993 - Writing Down Goals N/A
Completed NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee Phase 2
Completed NCT02269254 - Persona Versus NexGen N/A
Completed NCT02256098 - RSA RCT: ATTUNEā„¢ TKA Versus PFC Sigma TKA N/A
Completed NCT02257489 - Phase 1 Study of ACE-083 in Healthy Subjects Phase 1
Completed NCT01979731 - Effects Job Rotation in the Prevention of Work Related Musculoskeletal Disorders N/A
Active, not recruiting NCT01440153 - Additional Exercise Program in Professional Dancers N/A
Completed NCT00968266 - Improving Beliefs About Medication in Patients With Rheumatoid Arthritis N/A
Completed NCT05222126 - Efficacy of Ultrasound-Guided Hydrodissection in Carpal Tunnel Syndrome N/A
Completed NCT05062694 - Physical Therapy Management Of The Patient With Central Sensitization
Recruiting NCT05564182 - High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain N/A
Completed NCT04009369 - Impacts of Physiotherapy Services in a Quebec Emergency Department N/A
Completed NCT05561452 - The Efficacy of PRP Injection in the Treatment of Rotator Cuff Syndrome N/A
Recruiting NCT05432609 - Standardization and Reproducibility Regarding Scanning Procedures and Measurements of Weight-bearing Cone Beam CT in the Lower Extremity
Completed NCT04959162 - The Effect of Theoretical Knowledge on Resident's Practical Performance in Musculoskeletal Ultrasound N/A